These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 20186129)

  • 1. Cardioprotective effects of a selective B(2) receptor agonist of bradykinin post-acute myocardial infarct.
    Marketou M; Kintsurashvili E; Papanicolaou KN; Lucero HA; Gavras I; Gavras H
    Am J Hypertens; 2010 May; 23(5):562-8. PubMed ID: 20186129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bradykinin B2 receptor agonism: a novel therapeutic strategy for myocardial infarction?
    Duchene J; Bader M
    Am J Hypertens; 2010 May; 23(5):459. PubMed ID: 20404805
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardioprotective properties of bradykinin: role of the B(2) receptor.
    Manolis AJ; Marketou ME; Gavras I; Gavras H
    Hypertens Res; 2010 Aug; 33(8):772-7. PubMed ID: 20505673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postinfarct treatment with oxytocin improves cardiac function and remodeling via activating cell-survival signals and angiogenesis.
    Kobayashi H; Yasuda S; Bao N; Iwasa M; Kawamura I; Yamada Y; Yamaki T; Sumi S; Ushikoshi H; Nishigaki K; Takemura G; Fujiwara T; Fujiwara H; Minatoguchi S
    J Cardiovasc Pharmacol; 2009 Dec; 54(6):510-9. PubMed ID: 19755919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid receptor agonist Eribis peptide 94 reduces infarct size in different porcine models for myocardial ischaemia and reperfusion.
    Karlsson LO; Grip L; Bissessar E; Bobrova I; Gustafsson T; Kavianipour M; Odenstedt J; Wikström G; Gonon AT
    Eur J Pharmacol; 2011 Jan; 651(1-3):146-51. PubMed ID: 21093430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibition after experimental myocardial infarct: role of the kinin B1 and B2 receptors.
    Duka A; Kintsurashvili E; Duka I; Ona D; Hopkins TA; Bader M; Gavras I; Gavras H
    Hypertension; 2008 May; 51(5):1352-7. PubMed ID: 18347228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioprotective effect of angiotensin II type 1 receptor antagonist associated with bradykinin-endothelial nitric oxide synthase and oxidative stress in Dahl salt-sensitive hypertensive rats.
    Yoshida K; Kobayashi N; Ohno T; Fukushima H; Matsuoka H
    J Hypertens; 2007 Aug; 25(8):1633-42. PubMed ID: 17620960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of the mediators involved in the protection induced by exogenous kinins in the isolated rat heart.
    Lagneux C; Adam A; Lamontagne D
    Int Immunopharmacol; 2003 Oct; 3(10-11):1511-8. PubMed ID: 12946448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue kallikrein is involved in the cardioprotective effect of AT1-receptor blockade in acute myocardial ischemia.
    Messadi-Laribi E; Griol-Charhbili V; Pizard A; Vincent MP; Heudes D; Meneton P; Alhenc-Gelas F; Richer C
    J Pharmacol Exp Ther; 2007 Oct; 323(1):210-6. PubMed ID: 17636004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
    Hartman JC
    Ann Thorac Surg; 1995 Sep; 60(3):789-92. PubMed ID: 7545893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ARD-353 [4-((2R,5S)-4-(R)-(4-diethylcarbamoylphenyl)(3-hydroxyphenyl)methyl)-2,5-dimethylpiperazin-1-ylmethyl)benzoic acid], a novel nonpeptide delta receptor agonist, reduces myocardial infarct size without central effects.
    Watson MJ; Holt JD; O'Neill SJ; Wei K; Pendergast W; Gross GJ; Gengo PJ; Chang KJ
    J Pharmacol Exp Ther; 2006 Jan; 316(1):423-30. PubMed ID: 16188952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ace-inhibition with quinapril modulates the nitric oxide pathway in normotensive rats.
    Bachetti T; Comini L; Pasini E; Cargnoni A; Curello S; Ferrari R
    J Mol Cell Cardiol; 2001 Mar; 33(3):395-403. PubMed ID: 11181009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bradykinin B2 receptor antagonism attenuates inflammation, mast cell infiltration and fibrosis in remote myocardium after infarction in rats.
    Koike MK; de Carvalho Frimm C; de Lourdes Higuchi M
    Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1131-6. PubMed ID: 16445581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective tumor blood-brain barrier opening with the kinin B2 receptor agonist [Phe(8)psi(CH(2)NH)Arg(9)]-BK in a F98 glioma rat model: an MRI study.
    Côté J; Savard M; Bovenzi V; Dubuc C; Tremblay L; Tsanaclis AM; Fortin D; Lepage M; Gobeil F
    Neuropeptides; 2010 Apr; 44(2):177-85. PubMed ID: 20080302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioprotection and kallikrein-kinin system in acute myocardial ischaemia in mice.
    Messadi-Laribi E; Griol-Charhbili V; Gaies E; Vincent MP; Heudes D; Meneton P; Alhenc-Gelas F; Richer C
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):489-93. PubMed ID: 18307747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of TGF-beta1 signaling by eNOS gene transfer improves ventricular remodeling after myocardial infarction through angiogenesis and reduction of apoptosis.
    Chen LL; Yin H; Huang J
    Cardiovasc Pathol; 2007; 16(4):221-30. PubMed ID: 17637430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-9972 (D-Arg-[Hyp3,Igl5,Oic7,Igl8]-bradykinin) is an inactivation-resistant agonist of the bradykinin B2 receptor derived from the peptide antagonist B-9430 (D-Arg-[Hyp3,Igl5,D-Igl7,Oic8]-bradykinin): pharmacologic profile and effective induction of receptor degradation.
    Bawolak MT; Gera L; Morissette G; Stewart JM; Marceau F
    J Pharmacol Exp Ther; 2007 Nov; 323(2):534-46. PubMed ID: 17699739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain natriuretic peptide limits myocardial infarct size dependent of nitric oxide synthase in rats.
    Ren B; Shen Y; Shao H; Qian J; Wu H; Jing H
    Clin Chim Acta; 2007 Feb; 377(1-2):83-7. PubMed ID: 17026975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the signal cascade mechanism mediating the cardioprotective actions of bradykinin.
    Akula A; Veeravalli KK; Potharaju S; Kota MK
    Pharmazie; 2002 May; 57(5):332-6. PubMed ID: 12061258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences between peptide and nonpeptide B(2) bradykinin receptor antagonists in blocking bronchoconstriction and hypotension induced by bradykinin in anesthetized Guinea pigs.
    Tramontana M; Lecci A; Meini S; Montserrat X; Pascual J; Giuliani S; Quartara L; Maggi CA
    J Pharmacol Exp Ther; 2001 Mar; 296(3):1051-7. PubMed ID: 11181940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.